BA-86-YY52_0.01uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=0.01uM, (2S,7R)-4-methyl-4,9-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(15),12(16),13-triene, 5-HT2C Antagonists;5-HT2B Antagonists targeting HTR2B, HTR2C (Novartis, 14988831)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/14988831
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
10 genes differentially expressed following the BA-86-YY52_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
RPL31
|
ribosomal protein L31
|
1.25814
|
|
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae)
|
0.284643
|
|
ATP5MF
|
ATP synthase membrane subunit f
|
0.272406
|
|
FAU
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed
|
0.256516
|
|
RPS19
|
ribosomal protein S19
|
0.239019
|
|
COX5B
|
cytochrome c oxidase subunit Vb
|
0.231393
|
|
TMSB10
|
thymosin beta 10
|
0.222542
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
-0.407308
|
|
LRRC37B
|
leucine rich repeat containing 37B
|
-0.261879
|
|
RPL11
|
ribosomal protein L11
|
-0.257525
|